BGC-728

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBGC-728
Drug Alias NameBGC-728
ClassificationBiologics
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsMyocardial InfarctionStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBtg Plc
China Registration ClassN/A

Develop Information

Active CompaniesBtg Plc
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A